The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Osteoprotegerin, vascular calcification and atherosclerosis
Open accessAbstract
The association of bone pathologies with atherosclerosis has stimulated the search for common mediators linking the skeletal and the vascular system. Since its initial discovery as a key regulator in bone metabolism, osteoprotegerin (OPG) has become the subject of intense interest for its role in vascular disease and calcification. Studies in vitro and in animal models suggest that OPG inhibits vascular calcification. Paradoxically however, clinical studies suggest that serum OPG levels increase in association with vascular calcification, coronary artery disease, stroke and future cardiovascular events. This has led to extensive debate on the potential of OPG as a biomarker of vascular disease. However the exact significance and mechanisms by which this bone-regulatory protein influences cardiovascular pathophysiology is still unclear. The need for a more complete picture is being addressed in increasing valuable research indicating OPG as not only a marker but also a mediator of vascular pathology modulating osteogenic, inflammatory and apoptotic responses. By integrating the results of recent experimental research, animal models and clinical studies, this review summarises the present understanding of the role of OPG in vascular disease and calcification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 2×
“RANKL expressed n osteoblastic, stromal and T cells binds to RANK on the surface f osteoclasts, monocytic and dendritic cells [13].”
BackgroundOsteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL
Emery, J. G., McDonnell, P., Burke, M. B., Deen, K. C., Lyn, S., Silverman, C., Dul, E., Appelbaum, E. R., Eichman, C., DiPrinzio, R., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14363 · Cited by 1,184
Bone morphogenetic protein expression in human atherosclerotic lesions.
Boström, K., Watson, K. E., Horn, S., Wortham, C., Herman, I. M., & Demer, L. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116391 · Cited by 1,020
Clinical Implications of the Osteoprotegerin/RANKL/RANK System for Bone and Vascular Diseases
Hofbauer, L. C. (2004) · JAMA · doi:10.1001/jama.292.4.490 · Cited by 988
Endothelial Function: A Critical Determinant in Atherosclerosis?
Landmesser, U., Hornig, B., & Drexler, H. (2004) · Circulation · doi:10.1161/01.cir.0000129501.88485.1f · Cited by 851
Steitz, S. A., Speer, M. Y., Curinga, G., Yang, H.-Y., Haynes, P., Aebersold, R., Schinke, T., Karsenty, G., & Giachelli, C. M. (2001) · Circulation Research · doi:10.1161/hh2401.101070 · Cited by 822
Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.
Tsuda, E., Goto, M., Mochizuki, S.-I., Yano, K., Kobayashi, F., Morinaga, T., & Higashio, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6603 · Cited by 787
Oxidative stress modulates osteoblastic differentiation of vascular and bone cells
Mody, N. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00610-4 · Cited by 781
Proudfoot, D., Skepper, J. N., Hegyi, L., Bennett, M. R., Shanahan, C. M., & Weissberg, P. L. (2000) · Circulation Research · doi:10.1161/01.res.87.11.1055 · Cited by 719
Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic Plaques
Dhore, C. R., Cleutjens, J. P. M., Lutgens, E., Cleutjens, K. B. J. M., Geusens, P. P. M., Kitslaar, P. J. E. H. M., Tordoir, J. H. M., Spronk, H. M. H., Vermeer, C., & Daemen, M. J. A. P. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1201.100229 · Cited by 708
Bennett, M. R., Evan, G. I., & Schwartz, S. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117917 · Cited by 703
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Cited by 650
Tabas, I. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000184783.04864.9f · Cited by 641
Parhami, F., Morrow, A. D., Balucan, J., Leitinger, N., Watson, A. D., Tintut, Y., Berliner, J. A., & Demer, L. L. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.4.680 · Cited by 619
Min, H., Morony, S., Sarosi, I., Dunstan, C. R., Capparelli, C., Scully, S., Van, G., Kaufman, S., Kostenuik, P. J., Lacey, D. L., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.463 · Cited by 550
Tumor Necrosis Factor-α Promotes In Vitro Calcification of Vascular Cells via the cAMP Pathway
Tintut, Y., Patel, J., Parhami, F., & Demer, L. L. (2000) · Circulation · doi:10.1161/01.cir.102.21.2636 · Cited by 527
Browner, W. S., Lui, L.-Y., & Cummings, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7192 · Cited by 506
Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease
Kiechl, S., Schett, G., Wenning, G., Redlich, K., Oberhollenzer, M., Mayr, A., Santer, P., Smolen, J., Poewe, W., & Willeit, J. (2004) · Circulation · doi:10.1161/01.cir.0000127957.43874.bb · Cited by 505
Jono, S., Ikari, Y., Shioi, A., Mori, K., Miki, T., Hara, K., & Nishizawa, Y. (2002) · Circulation · doi:10.1161/01.cir.0000031524.49139.29 · Cited by 489
Kiel, D. P., Kauppila, L. I., Cupples, L. A., Hannan, M. T., O'Donnell, C. J., & Wilson, P. W. F. (2001) · Calcified Tissue International · doi:10.1007/bf02390833 · Cited by 483
Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin
Collin-Osdoby, P. (2004) · Circulation Research · doi:10.1161/01.res.0000149165.99974.12 · Cited by 473
Aortic calcification and the risk of osteoporosis and fractures.
Schulz, E., Arfai, K., Liu, X., Sayre, J., & Gilsanz, V. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030964 · Cited by 429
Circulating Osteoblast-Lineage Cells in Humans
Eghbali-Fatourechi, G. Z., Lamsam, J., Fraser, D., Nagel, D., Riggs, B. L., & Khosla, S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044264 · Cited by 418
RANK Ligand and Osteoprotegerin: Paracrine Regulators of Bone Metabolism and Vascular Function
Schoppet, M., Preissner, K. T., & Hofbauer, L. C. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000012303.37971.da · Cited by 405
Collin-Osdoby, P., Rothe, L., Anderson, F., Nelson, M., Maloney, W., & Osdoby, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010153200 · Cited by 398
Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D.
Price, P. A., June, H. H., Buckley, J. R., & Williamson, M. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1001.097102 · Cited by 376
Hak, A. E., Pols, H. A. P., van Hemert, A. M., Hofman, A., & Witteman, J. C. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1926 · Cited by 375
Nadra, I., Mason, J. C., Philippidis, P., Florey, O., Smythe, C. D. W., McCarthy, G. M., Landis, R. C., & Haskard, D. O. (2005) · Circulation Research · doi:10.1161/01.res.0000171451.88616.c2 · Cited by 360
Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells
Malyankar, U. M., Scatena, M., Suchland, K. L., Yun, T. J., Clark, E. A., & Giachelli, C. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000290200 · Cited by 351
Monocyte/Macrophage Regulation of Vascular Calcification In Vitro
Tintut, Y., Patel, J., Territo, M., Saini, T., Parhami, F., & Demer, L. L. (2002) · Circulation · doi:10.1161/hc0502.102969 · Cited by 336
Increased Osteoprotegerin Serum Levels in Men with Coronary Artery Disease
Schoppet, M., Sattler, A. M., Schaefer, J. R., Herzum, M., Maisch, B., & Hofbauer, L. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020775 · Cited by 324
Bennett, B. J., Scatena, M., Kirk, E. A., Rattazzi, M., Varon, R. M., Averill, M., Schwartz, S. M., Giachelli, C. M., & Rosenfeld, M. E. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000236428.91125.e6 · Cited by 304 · cited 5×
“In support of a beneficial vascular role for OPG is the recent nding of accelerated atherosclerotic lesion progression in OPG eficient mice [11].”
BackgroundInfluentialKaden, J. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.09.015 · Cited by 285
Shioi, A., Katagi, M., Okuno, Y., Mori, K., Jono, S., Koyama, H., & Nishizawa, Y. (2002) · Circulation Research · doi:10.1161/01.res.0000026421.61398.f2 · Cited by 280
Browner, W. S. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.631 · Cited by 260
Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr (−/−) Mice
Morony, S., Tintut, Y., Zhang, Z., Cattley, R. C., Van, G., Dwyer, D., Stolina, M., Kostenuik, P. J., & Demer, L. L. (2008) · Circulation · doi:10.1161/circulationaha.107.707380 · Cited by 258 · cited 3×
“Moreover, OPG locks the actions of RANKL which is found increased in diseased nd calcified vessels [22,25,67] and can in vitro induce ALP activity nd calcification in vascular cells [67].”
BackgroundVascular calcification and osteoporosis—from clinical observation towards molecular understanding
Hofbauer, L. C., Brueck, C. C., Shanahan, C. M., Schoppet, M., & Dobnig, H. (2007) · Osteoporosis International · doi:10.1007/s00198-006-0282-z · Cited by 248
Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification
IYEMERE, V. P., PROUDFOOT, D., WEISSBERG, P. L., & SHANAHAN, C. M. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01692.x · Cited by 246
Osteoprotegerin Serum Levels in Men: Correlation with Age, Estrogen, and Testosterone Status1
Szulc, P., Hofbauer, L. C., Heufelder, A. E., Roth, S., & Delmas, P. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7657 · Cited by 234
Low Bone Mineral Density in the Hip as a Marker of Advanced Atherosclerosis in Elderly Women
Tankó, L. B., Bagger, Y. Z., & Christiansen, C. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-2070-x · Cited by 227
Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart Failure
Ueland, T., Yndestad, A., Øie, E., Florholmen, G., Halvorsen, B., Frøland, S. S., Simonsen, S., Christensen, G., Gullestad, L., & Aukrust, P. (2005) · Circulation · doi:10.1161/01.cir.0000165119.62099.14 · Cited by 227
Golledge, J., McCann, M., Mangan, S., Lam, A., & Karan, M. (2004) · Stroke · doi:10.1161/01.str.0000129790.00318.a3 · Cited by 222
Self-citationHofbauer, L. C., Shui, C., Riggs, B. L., Dunstan, C. R., Spelsberg, T. C., O'Brien, T., & Khosla, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4130 · Cited by 211
Circulating Osteoprotegerin Levels and Long-Term Prognosis in Patients With Acute Coronary Syndromes
Omland, T., Ueland, T., Jansson, A. M., Persson, A., Karlsson, T., Smith, C., Herlitz, J., Aukrust, P., Hartford, M., & Caidahl, K. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.058 · Cited by 205
Ziolkowska, M., Kurowska, M., Radzikowska, A., Luszczykiewicz, G., Wiland, P., Dziewczopolski, W., Filipowicz‐Sosnowska, A., Pazdur, J., Szechinski, J., Kowalczewski, J., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10388 · Cited by 200
Walsh, M. C., & Choi, Y. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00027-3 · Cited by 200
BAGGER, Y. Z., TANKÓ, L. B., ALEXANDERSEN, P., QIN, G., CHRISTIANSEN, C., & THE PROSPECTIVE EPIDEMIOLOGICAL RISK FACTORS STUDY GROUP (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01640.x · Cited by 198
Yun, T. J., Tallquist, M. D., Aicher, A., Rafferty, K. L., Marshall, A. J., Moon, J. J., Ewings, M. K., Mohaupt, M., Herring, S. W., & Clark, E. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1482 · Cited by 195
The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease
Kiechl, S., Werner, P., Knoflach, M., Furtner, M., Willeit, J., & Schett, G. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.6.801 · Cited by 195
Anand, D. V., Lahiri, A., Lim, E., Hopkins, D., & Corder, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.054 · Cited by 193
Nitta, K., Akiba, T., Uchida, K., Kawashima, A., Yumura, W., Kabaya, T., & Nihei, H. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00655-3 · Cited by 188
Serum levels of osteoprotegerin increase with age in a healthy adult population.
Kudlacek, S., Schneider, B., Woloszczuk, W., Pietschmann, P., & Willvonseder, R. (2003) · Bone · doi:10.1016/s8756-3282(03)00090-5 · Cited by 187
Schoppet, M., Al-Fakhri, N., Franke, F. E., Katz, N., Barth, P. J., Maisch, B., Preissner, K. T., & Hofbauer, L. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031432 · Cited by 184
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction
Ueland, T., Jemtland, R., Godang, K., Kjekshus, J., Hognestad, A., Omland, T., Squire, I. B., Gullestad, L., Bollerslev, J., Dickstein, K., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.076 · Cited by 182
Sandberg, W. J., Yndestad, A., Øie, E., Smith, C., Ueland, T., Ovchinnikova, O., Robertson, A.-K. L., Müller, F., Semb, A. G., Scholz, H., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000204334.48195.6a · Cited by 182
Relation of Osteoprotegerin to Coronary Calcium and Aortic Plaque (from the Dallas Heart Study)
Abedin, M., Omland, T., Ueland, T., Khera, A., Aukrust, P., Murphy, S. A., Jain, T., Gruntmanis, U., McGuire, D. K., & de Lemos, J. A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.08.064 · Cited by 180
Sato, K., Niessner, A., Kopecky, S. L., Frye, R. L., Goronzy, J. J., & Weyand, C. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051062 · Cited by 176
Knudsen, S., Foss, C., Poulsen, P., Andersen, N., Mogensen, C., & Rasmussen, L. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490039 · Cited by 176
Plasma Osteoprotegerin Is Associated with Mortality in Hemodialysis Patients
Morena, M., Terrier, N., Jaussent, I., Leray-Moragues, H., Chalabi, L., Rivory, J.-P., Maurice, F. C., Delcourt, C., Cristol, J.-P., Canaud, B., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030260 · Cited by 171
Determinants of Progression of Coronary Artery Calcification in Type 2 Diabetes
Anand, D. V., Lim, E., Darko, D., Bassett, P., Hopkins, D., Lipkin, D., Corder, R., & Lahiri, A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.08.032 · Cited by 170
Secchiero, P., Candido, R., Corallini, F., Zacchigna, S., Toffoli, B., Rimondi, E., Fabris, B., Giacca, M., & Zauli, G. (2006) · Circulation · doi:10.1161/circulationaha.106.643841 · Cited by 163
PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways
Zhang, J., Fu, M., Myles, D., Zhu, X., Du, J., Cao, X., & Chen, Y. E. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02872-7 · Cited by 160
Secchiero, P., Corallini, F., Pandolfi, A., Consoli, A., Candido, R., Fabris, B., Celeghini, C., Capitani, S., & Zauli, G. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060398 · Cited by 160
Rasmussen, L. M., Tarnow, L., Hansen, T. K., Parving, H., & Flyvbjerg, A. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02049 · Cited by 159
Association of Osteoprotegerin With Human Abdominal Aortic Aneurysm Progression
Moran, C. S., McCann, M., Karan, M., Norman, P., Ketheesan, N., & Golledge, J. (2005) · Circulation · doi:10.1161/circulationaha.104.464727 · Cited by 158
Self-citationBarreto, D. V., Barreto, F. C., Carvalho, A. B., Cuppari, L., Cendoroglo, M., Draibe, S. A., Moyses, R. M. A., Neves, K. R., Jorgetti, V., Blair, A., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00239.x · Cited by 158
Pritzker, L. B., Scatena, M., & Giachelli, C. M. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-01-0059 · Cited by 156
Olesen, P., Ledet, T., & Rasmussen, L. M. (2005) · Diabetologia · doi:10.1007/s00125-004-1652-8 · Cited by 152
Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.
Kaden, J. J., Bickelhaupt, S., Grobholz, R., Vahl, C. F., Hagl, S., Brueckmann, M., Haase, K. K., Dempfle, C.-E. H., & Borggrefe, M. M. (2004) · PubMed · Cited by 148
Characterization of circulating osteoblast lineage cells in humans
Eghbali-Fatourechi, G. Z., Mödder, U. I., Charatcharoenwitthaya, N., Sanyal, A., Undale, A. H., Clowes, J. A., Tarara, J. E., & Khosla, S. (2007) · Bone · doi:10.1016/j.bone.2006.12.064 · Cited by 142
Novel Aspects on RANK Ligand and Osteoprotegerin in Osteoporosis and Vascular Disease
Sattler, A., Schoppet, M., Schaefer, J. R., & Hofbauer, L. C. (2003) · Calcified Tissue International · doi:10.1007/s00223-003-0011-y · Cited by 140
Osteoprotegerin Serum Levels in Men: Correlation with Age, Estrogen, and Testosterone Status
Szulc, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.3162 · Cited by 140
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells
Secchiero, P., Zerbinati, C., Rimondi, E., Corallini, F., Milani, D., Grill, V., Forti, G., Capitani, S., & Zauli, G. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4197-6 · Cited by 139
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo
Zauli, G., Corallini, F., Bossi, F., Fabio Fischetti, I., Durigutto, P., Celeghini, C., Tedesco, F., & Secchiero, P. (2007) · Blood · doi:10.1182/blood-2007-01-068395 · Cited by 138
Simionescu, A., Simionescu, D. T., & Vyavahare, N. R. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060930 · Cited by 134
Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease
Ziegler, S., Kudlacek, S., Luger, A., & Minar, E. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.01.042 · Cited by 131
Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients
Nitta, K., Akiba, T., Uchida, K., Otsubo, S., Takei, T., Yumura, W., Kabaya, T., & Nihei, H. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh263 · Cited by 129
Mangan, S., Campenhout, A. V., Rush, C. M., & Golledge, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.07.017 · Cited by 124
Self-citationKavurma, M. M., Schoppet, M., Bobryshev, Y. V., Khachigian, L. M., & Bennett, M. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706927200 · Cited by 112
Expression of mineralisation-regulating proteins in association with human vascular calcification
Shanahan, C. M., Proudfoot, D., Tyson, K. L., et al. (2000) · Zeitschrift für Kardiologie · doi:10.1007/s003920070101 · Cited by 106
Osteoprotegerin Gene Polymorphisms in Men with Coronary Artery Disease
Soufi, M., Schoppet, M., Sattler, A., Herzum, M., Maisch, B., Hofbauer, L. C., & Schaefer, J. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032054 · Cited by 103
Syndecan-1 Is Involved in Osteoprotegerin-Induced Chemotaxis in Human Peripheral Blood Monocytes
Mosheimer, B. A., Kaneider, N. C., Feistritzer, C., Djanani, A. M., Sturn, D. H., Patsch, J. R., & Wiedermann, C. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1895 · Cited by 99
Paradoxical Effects of Statins on Aortic Valve Myofibroblasts and Osteoblasts
Wu, B., Elmariah, S., Kaplan, F. S., Cheng, G., & Mohler, E. R. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000154278.01871.64 · Cited by 97
Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction
Crisafulli, A., Micari, A., Altavilla, D., Saporito, F., Sardella, A., Passaniti, M., Raffa, S., D'Anneo, G., Lucà, F., Mioni, C., et al. (2005) · Clinical Science · doi:10.1042/cs20050058 · Cited by 95
Circulating Cells with Osteogenic Potential
Khosla, S., & Eghbali-Fatourechi, G. Z. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.022 · Cited by 85
Role of Osteoprotegerin in Arterial Calcification: Development of New Animal Model
Orita, Y., Yamamoto, H., Kohno, N., Sugihara, M., Honda, H., Kawamata, S., Mito, S., Soe, N. N., & Yoshizumi, M. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.147868 · Cited by 85
Asanuma, Y., Chung, C. P., Oeser, A. M., Solus, J. F., Avalos, I., Gebretsadik, T. S., Shintani, A., Raggi, P., Sokka, T., Pincus, T., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.04.049 · Cited by 84
Shin, J. Y., Shin, Y. G., & Chung, C. H. (2006) · Diabetes Care · doi:10.2337/dc06-0631 · Cited by 83
Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity
Kim, S. M., Lee, J., Ryu, O., Lee, K. W., Kim, H. Y., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., et al. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02390.x · Cited by 81
Rhee, E., Lee, W., Kim, S.-Y., Kim, B. J., Sung, K., Kim, B.-S., Kang, J.-H., Oh, K.-W., Eun-Sook, O. H., Baek, K., et al. (2005) · Clinical Science · doi:10.1042/cs20040255 · Cited by 79
Omland, T., Drazner, M. H., Ueland, T., Abedin, M., Murphy, S. A., Aukrust, P., & de Lemos, J. A. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.087742 · Cited by 78
Gannagé‐Yared, M., Fares, F., Semaan, M., Khalife, S., & Jambart, S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02522.x · Cited by 76 · cited 1×
“[95] Gannage-Yared MH, Fares F, Semaan M, et al.”
Avignon, A., Sultan, A., Piot, C. A., Mariano‐Goulart, D., Dieudonné, J.-F. T. D., Cristol, J., & Dupuy, A. (2007) · Diabetes Care · doi:10.2337/dc07-0992 · Cited by 75
TRAIL expression in vascular smooth muscle
Gochuico, B. R., Zhang, J., Yang, B., Marshak‐Rothstein, A., & Fine, A. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.278.5.l1045 · Cited by 68
Fu, M., Zhang, J., Lin, Y. G., Zhu, X., Willson, T. M., & Chen, Y. E. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00533-8 · Cited by 66
Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients
Xiang, G., Sun, H., & Lin-shuang, Z. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.09.008 · Cited by 62
Oh, E. S., Rhee, E.-J., Oh, K. W., Lee, W. Y., Baek, K. H., Yoon, K. H., Kang, M. I., Yun, E. J., Park, C. Y., Choi, M. G., et al. (2005) · Metabolism · doi:10.1016/j.metabol.2004.08.005 · Cited by 61
Assessment of a Serum Assay for Quantification of Abdominal Aortic Calcification
Clancy, P., Oliver, L., Jayalath, R., Buttner, P. G., & Golledge, J. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000242799.81434.7d · Cited by 53
Self-citationHelske, S., Kovanen, P. T., Lindstedt, K. A., Salmela, K. T., Lommi, J., Turto, H., Werkkala, K., & Kupari, M. M. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.10.015 · Cited by 50
Cohen, E. B.-T., Hohensinner, P. J., Kaun, C., Maurer, G., Huber, K., & Wojta, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.09.007 · Cited by 47
Role of Osteoprotegerin and Its Ligands and Competing Receptors in Atherosclerotic Calcification
Tintut, Y., & Demer, L. L. (2006) · Journal of Investigative Medicine · doi:10.2310/6650.2006.06019 · Cited by 46
Schoppet, M., Ruppert, V., Hofbauer, L. C., Henser, S., Al‐Fakhri, N., Christ, M., Pankuweit, S., & Maisch, B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.136 · Cited by 29
Determinants of Endothelial Function in a Cohort of Patients with Peripheral Artery Disease
Golledge, J., Leicht, A. S., Crowther, R. G., Glanville, S., Clancy, P., Sangla, K. S., Spinks, W. L., & Quigley, F. (2008) · Cardiology · doi:10.1159/000113428 · Cited by 28
Self-citationOvariectomy increases vascular calcification via the OPG/RANKL cytokine signalling pathway
Choi, B. G., Vilahur, G., Cardoso, L., Fritton, J. C., Ibáñez, B., Zafar, M. U., Yadegar, D., Speidl, W. S., Schaffler, M. B., Fuster, V., et al. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01930.x · Cited by 27
Association between osteoprotegerin gene polymorphism and coronary artery disease in Japanese men
Ohmori, R., Momiyama, Y., Taniguchi, H., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.026 · Cited by 21
Preclinical vascular damage in white postmenopausal women: the relevance of osteoprotegerin
Siepi, D., Marchesi, S., Vaudo, G., Lupattelli, G., Bagaglia, F., Pirro, M., Brozzetti, M., Roscini, A. R., & Mannarino, E. (2008) · Metabolism · doi:10.1016/j.metabol.2007.10.005 · Cited by 19
Cited by
Vascular Calcification—New Insights into Its Mechanism
Lee, S. J., Lee, I.-K., & Jeon, J.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082685 · Cited by 438
Vascular calcification and bone disease: the calcification paradox
Persy, V., & D’Haese, P. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.07.001 · Cited by 332
Coronary Artery Calcium Progression: An Important Clinical Measurement?
McEvoy, J. W., Blaha, M. J., DeFilippis, A. P., Budoff, M. J., Nasir, K., Blumenthal, R. S., & Jones, S. R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.038 · Cited by 255
Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
Stojanović, S. D., Fiedler, J., Bauersachs, J., Thum, T., & Sedding, D. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz919 · Cited by 188
Garavelli, S., Bruzzaniti, S., Tagliabue, E., Di Silvestre, D., Prattichizzo, F., Mozzillo, E., Fattorusso, V., La Sala, L., Ceriello, A., Puca, A. A., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05237-x · Cited by 37
Metadata
- Authors
- Van Campenhout, A., & Golledge, J.
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 204
- Issue
- 2
- Pages
- 321-329
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W2160271093
- Cited by
- 308
- References
- 110
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.